With the tariff threat headache over, time to focus on them again? 8 pharma stocks with upside potential of up to 39%With a clear indication that no additional or special tariff will be imposed by the US on generic drugs, there is a sense of relief among I...
13 Oct, 2025, 03.05 PM IST
Sometimes, ignoring all noise is the best option: 7 large-cap stocks from different sectors with an upside potential of up to 38%What is it that the street fears most when it comes to a slowdown or any other disruption (tariffs, or a sudden increase in commodity price...
18 Aug, 2025, 05.38 AM IST
Nothing wrong in being bullish, if you know why & what you are doing: 7 large-cap stocks with an upside potential of 2 to 20%In the short term, what Trump says, the numbers from China, and what the US Fed does will determine stock prices. But in the long term, the...
22 Jul, 2025, 02.49 PM IST
Best way to deal with volatility, just “ Hold” for wealth creation: 7 large-cap stocks with an upside potential of up to 41%If you are a long-term investor, your decisions cannot be based on what the Nifty or Sensex do every week, or even every quarter. So, if yo...
19 Jul, 2025, 12.16 PM IST
One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
03 Jul, 2025, 12.48 PM IST
Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
14 Jan, 2025, 02.13 PM IST
Tailwinds and stronger balance sheets: 5 large-cap stocks with the right mix of two ratios & upside potential of up to 32%A crucial contribution to the growth of a business is the overall size of the market for its product or services. And by market size we mea...
09 Dec, 2024, 05.00 AM IST
Why predict time and magnitude of correction, focus on business and diversification: 6 large-cap stocks with upside potential of up to 38%After a long time, probably after March 2024, stock prices and the indices have corrected in a very sharp manner – and across the board. Th...
06 Oct, 2024, 07.53 AM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 44%With Nifty and Sensex touching a new high, bullish sentiment has further spread on the Street. It is not very obvious but some of the pre-e...
31 Aug, 2024, 05.45 AM IST
Sectoral tailwinds and stronger balance sheets: 5 largecap stocks with right mix of two important ratiosThere are some sectors where large players have an edge, because the nature of the business is such that there are phases where ability to ...
20 Jan, 2024, 02.56 PM IST
Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
04 Jan, 2024, 02.09 PM IST
Good for all market conditions: 6 largecap stocks with right mix of RoE & RoCEThere is sunshine all around, better than expected GDP numbers, further decline in oil prices, falling US bond yields and clear indication ...
16 Dec, 2023, 01.47 PM IST
Torrent, Zydus in co-marketing pact for liver disease drug SaroglitazarTorrent Pharmaceuticals and Zydus Lifesciences formed a licensing and supply pact to co-market Saroglitazar Mg, the sole approved treatment...
10 Nov, 2023, 04.54 PM IST
Zydus, Lupin enter licensing pact to market drug to treat liver diseaseZydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing...
03 Nov, 2023, 07.38 PM IST
Lupin, Zydus Lifesciences ink licensing, supply pact for Saroglitazar MgLupin and Zydus Lifesciences entered into a licensing and supply agreement to co-market Saroglitazar Mg, an innovative drug approved by Ind...
03 Nov, 2023, 04.03 PM IST
Zydus bets big on proprietary drugs to boost revenueSharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards develo...
03 Nov, 2023, 12.43 AM IST
Tailwinds at the right time: 7 pharma stocks with an upside potential up to 37 %It is not very common to see tailwinds emerging for an industry at a time when it is ideal to own stocks from that space. But in the case o...
07 Oct, 2023, 11.11 PM IST